Calls for the Immediate Resignation of Four Directors, Including Chairman Peter Staple, Heather Mason, William McKee and Dr. Jeffrey Vacirca
Intends to Nominate Independent, Qualified Directors at the Company's Next Shareholder Meeting If No Progress is Made
Criticizes Board's Failure to Explain and Recover Damages From Value-Destructive Spectrum Pharmaceuticals Acquisition
Urges Board to Improve its Due Diligence Process Before Any Further M&A
The Buxton Helmsley Group, Inc., a significant shareholder of Assertio Holdings, Inc. (NASDAQ:ASRT), today issued the following letter to the company's Board of Directors.